Abstract
Labor induction is used in approximately 20% of pregnancies in Europe and North America. Prostaglandins and prostaglandin analogs are favored when women undergoing labor induction have an unripe cervix. Controlled-release dinoprostone, delivered over 24 h from a vaginal insert, results in cervical ripening within 12 h in most women. It is marginally more effective than immediate release formulations and has similar efficacy to misoprostol, a prostaglandin E1 analog used off-label for this indication. The controlled-release preparation offers many advantages compared with an immediate-release formulation: a single application is sufficient; it is less invasive; it is easily administered and removed, allowing greater dose control. The most significant adverse effect, uterine hyperstimulation, with and without an effect on fetal heart rate, occurs in 5–15% of patients, which is comparable with other formulations or misoprostol. The insert can be removed easily on the first sign of uterine hyperstimulation, or as soon as labor starts. The efficacy and safety of controlled-release dinoprostone are comparable whether it is used in the outpatient or the inpatient setting. For low-risk women, outpatient use may be a highly attractive option, potentially reducing hospital costs, and improving patient convenience. The ease of use of controlled-release dinoprostone and women's satisfaction emphasize its benefits over many other agents used to ripen the cervix.
References
1 Anon: Induction of labor [ACOG technical bulletin]. Int J Gynaecol Obstet53 (1996) 65Search in Google Scholar
2 American College of Obstetricians Gynecologists: ACOG technical bulletin. Induction of labor. Int J Gynaecol Obstet53 (1996) 65Search in Google Scholar
3 American College of Obstetricians and Gynaecologists: Induction of labor. Practice bulletin no. 10. Washington, D.C.: ACOG, 1999Search in Google Scholar
4 Biem SRD, RW Turnell, O Olatunbosun, M Tauh, HJ Biem: A randomized controlled trial of outpatient vs. inpatient labor induction with vaginal controlled-release prostaglandin-E2: effectiveness and satisfaction. J Obstet Gynaecol Can25 (2003) 23Search in Google Scholar
5 Bishop EH: Pelvic scoring for elective induction. Obstet Gynecol24 (1964) 266Search in Google Scholar
6 Blair FC, SA Tassone, CR Pearman, MB St Cyr, WF Rayburn: Inducing labor with a sustained-release PGE2 vaginal insert. Experience at a community hospital. J Reprod Med43 (1998) 408Search in Google Scholar
7 Brest N, T Marlino, A Gerson: Outpatient cervical ripening with a dinoprostone vaginal insert. Today's Therapeutic Trends (In Press)Search in Google Scholar
8 Calder AA, MP Embrey, K Hillier: Extra-amniotic prostaglandin E2 for the induction of labor at term. J Obstet Gynaecol Br Commonw81 (1974) 39Search in Google Scholar
9 Calder AA: The management of the unripe cervix. In: Keirse MJNC, ABM Anderson, J Bennebroek Gravenhorst: Human Parturition. Leiden University Press, The Hague 197910.1007/978-94-009-9586-4_13Search in Google Scholar
10 Chyu JK, HT Strassner: Prostaglandin E2 for cervical ripening: a randomized comparison of Cervidil vs. Prepidil. Am J Obstet Gynecol177 (1997) 606Search in Google Scholar
11 Crane JM, KA Bennett: A meta-analysis of controlled-release prostaglandin for cervical ripening and labor induction. J Soc Obstet Gynaecol Canada22 (2000) 692Search in Google Scholar
12 Crowley P: Interventions for preventing or improving the outcome of delivery at or beyond term (Cochrane Review). The Cochrane Library (2004) 1Search in Google Scholar
13 D'Aniello G, C Bocchi, P Florio, E Ignacchiti, CG Guidoni, G Centini, et al.: Cervical ripening and induction of labor by prostaglandin E2: a comparison between intracervical gel and vaginal pessary. J Matern Fetal Med14 (2003) 158Search in Google Scholar
14 Edwards RK, DS Richards: Preinduction cervical assessment. Clin Obstet Gynecol43 (2000) 440Search in Google Scholar
15 Garry D, R Figuerosa, RB Kalish, CJ Catalano, D Maulik: Randomized controlled trial of vaginal misoprostol vs. dinoprostone vaginal insert for labor induction. J Matern Fetal Neonat Med13 (2003) 254Search in Google Scholar
16 Goharkhay N, FZ Stanczyk, E Gentzschein, DA Wing: Plasma prostaglandin E2 metabolite levels during labor induction with a sustained-release prostaglandin E2 vaginal insert. J Soc Gynecol Investig7 (2000) 338Search in Google Scholar
17 Hilder L, K Costeloe, B Thilaganathan: Prolonged pregnancy: evaluating gestation-specific risks of fetal and infant mortality. Br J Obstet Gynaecol105 (1998) 169Search in Google Scholar
18 Hofmeyr GJ, Z Alfirevic, J Kavanagh, J Thomas, P Brocklehurst, JP Neilson: Methods for cervical ripening and labor induction in late pregnancy: generic protocol. Cochrane Database Syst Rev 200010.1002/14651858.CD002074Search in Google Scholar
19 Hughes EG, AJ Kelly, J Kavanagh: Dinoprostone vaginal insert for cervical ripening and labor induction: a meta-analysis. Obstet Gynecol97 (2001) 847Search in Google Scholar
20 Keirse MJNC, ACA van Oppen: Preparing the cervix for induction of labor. In: Chalmers I, M Enkin, MJNC Keirse: Effective care in pregnancy and childbirth. Oxford University Press, Oxford 1989Search in Google Scholar
21 Keirse MJ: Prostaglandins in preinduction cervical ripening. Meta-analysis of worldwide clinical experience. J Reprod Med38 (1993) 89Search in Google Scholar
22 Kelly AJ, Z Alfirevic, GJ Hofmeyr, J Kavanagh, JP Neilson, J Thomas: Induction of labor in specific clinical situations: generic protocol. Cochrane Database Syst Rev 200110.1002/14651858.CD003398Search in Google Scholar
23 Kelly AJ, J Kavanagh, J Thomas: Vaginal prostaglandin (PGE2 and PGEF2a) for induction of labor at term. Cochrane Database Syst Rev 2003, 410.1002/14651858.CD003101Search in Google Scholar
24 Khoury AN, QP Zhou, DM Gorenberg, BM Nies, GE Manley, FE Mecklenburg: A comparison of intermittent vaginal administration of two different doses of misoprostol suppositories with continuous dinoprostone for cervical ripening and labor induction. J Matern Fetal Med10 (2001) 186Search in Google Scholar
25 Kozak LJ, JD Weeks: US trends in obstetric procedures, 1999–2000. Birth29 (2002) 157Search in Google Scholar
26 Ludmir J, HM Sehdev: Anatomy and physiology of the uterine cervix. Clin Obstet Gynecol43 (2000) 433Search in Google Scholar
27 Lyndrup J: Prostaglandins and induction of labor. Eur J Obstet Gynecol Reprod Biol64 (1996) 110.1016/0301-2115(95)02266-XSearch in Google Scholar
28 Lyrenas S, C Ingegerd, U Ulmsten: In vivo controlled release of PGE2 from a vaginal insert (0.8 mm, 10 mg) during induction of labor. Br J Obstet Gynaecol108 (2001) 169Search in Google Scholar
29 Miller AM, WF Rayburn, CV Smith: Patterns of uterine activity after intravaginal prostaglandin E2 during preinduction cervical ripening. Am J Obstet Gynecol165 (1991) 1006Search in Google Scholar
30 National Institute for Clinical Excellence, and the Royal College of Obstetricians and Gynaecologists: Induction of labor: Evidence-based clinical guideline. 2001Search in Google Scholar
31 Ottinger WS, MK Menard, BC Brost: A randomized clinical trial of prostaglandin E2 intracervical gel and a slow release vaginal pessary for preinduction cervical ripening. Am J Obstet Gynecol179 (1998) 349Search in Google Scholar
32 Perry MY, WL Leaphart. Randomized trial of intracervical vs. posterior fornix dinoprostone for induction of labor. Obstet Gynecol103 (2004) 13Search in Google Scholar
33 Rath W, C Bartz, M Winkler: Geburtseinleitung bei unreifer Zervix mit dem PGE2-Vaginalinsert Propess®—ergebnisse einer prospectiven randomisierten Multizenterstudie im Vergleich mit der intrazervikalen Applikation von Prostaglandin-E2-Gel (Prepidil®). Frauenartz43 (2002) 1173Search in Google Scholar
34 Rayburn WF, RJ Wapner, VA Barss, E Spitzberg, RD Molina, N Mandsager, et al.: An intravaginal controlled-release prostaglandin E2 pessary for cervical ripening and initiation of labor at term. Obstet Gynecol79 (1992) 374Search in Google Scholar
35 Rayburn WF: Clinical experience with a controlled-release, prostaglandin E2 intravaginal insert in the USA. Br J Obstet Gynaecol104 (Suppl 15) (1997) 8Search in Google Scholar
36 Sanchez-Ramos L, DE Peterson, J Delke, FL Gaudier, AM Kaunitz: Labor induction with prostaglandin E1 misoprostol compared with dinoprostone vaginal insert: A randomized trial. Obstet Gynecol91 (1998) 401Search in Google Scholar
37 Sennik BK: Outpatient use of a sustained-release PGE2 vaginal insert – a retrospective study. Today's Therapeutic Trends19 (2001) 77Search in Google Scholar
38 Simpson ML, O Von Lipinski, MG Radmanovic, NL Mitenko: Timed-release dinoprostone vaginal inserts in an outpatient and inpatient setting. Poster presented at ACOG Meeting, September 2004Search in Google Scholar
39 Smith CV, WF Rayburn, AM Miller: Intravaginal prostaglandin E2 for cervical ripening and initiation of labor. Comparison of a multidose gel and single, controlled-release pessary. J Reprod Med39 (1994) 381Search in Google Scholar
40 Taylor DR, AS Doughty, H Kaufman, L Yang, TA Iannucci: Uterine rupture with the use of PGE2 vaginal inserts for labor induction in women with previous caesarean sections. J Reprod Med47 (2002) 549Search in Google Scholar
41 Taylor SJ, CL Armour: Consumer preference for dinoprostone vaginal gel using stated preference discrete choice modelling. Pharmaeconomics21 (2003) 721Search in Google Scholar
42 Trofatter KF Jr: Endocervical prostaglandin E2 gel for preinduction cervical ripening. Clinical trials results. J Reprod Med38 (Suppl. 1) (1993) 78Search in Google Scholar
43 Vollebregt A, DB van't Hof, N Exalto: Prepidil compared to Propess for cervical ripening. Eur J Obstet Gynecol Reprod Biol104 (2002) 116Search in Google Scholar
44 Westgate J, JA Williams: Evaluation of a controlled release vaginal prostaglandin E2 pessary with a retrieval system for the induction of labor. J Obstet Gynaecol14 (1994) 146Search in Google Scholar
45 Wieland D, F Friedman Jr: Comparing two dinoprostone agents for preinduction cervical ripening at term: A randomized trial. J Reprod Med44 (1999) 724Search in Google Scholar
46 Wing DA, G Ortiz-Omphroy, RH Paul: A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction. Am J Obstet Gynecol177 (1997) 612Search in Google Scholar
47 Witter FR, LE Rocco, TRB Johnson: A randomised trial of prostaglandin E2 in a controlled-release vaginal pessary for cervical ripening at term. Am J Obstet Gynecol166 (1992) 830Search in Google Scholar
48 Witter FR, BM Mercer: Improved intravaginal controlled-release prostaglandin E2 insert for cervical ripening at term. The Prostaglandin E2 insert Study Group. J Matern Fetal Med5 (1996) 64Search in Google Scholar
49 Wong SF, SK Hui, H Choi, LC Ho: Does sweeping of membranes beyond 40 weeks reduce the need for formal induction of labour? BJOG109 (2002) 632Search in Google Scholar
©2005 by Walter de Gruyter Berlin New York
